Caffeine-loaded niosomes: Characterization and in vitro release studies

Drug Delivery

Volumn 14, Issue 7, 2007, Pages 447-452

  Khazaeli, Payam ^a   Pardakhty, Abbas ^a,b   Shoorabi, Hamideh ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Caffeine; Niosomes; Release; Sorbitan Monoester

Indexed keywords

CAFFEINE; CELLULOSE ACETATE; NIOSOME; SORBITAN LAURATE; SORBITAN OLEATE; SORBITAN PALMITATE; SORBITAN STEARATE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; ENCAPSULATION; LIPOPHILICITY; PARTICLE SIZE; PRIORITY JOURNAL; SOLID STATE;

ADMINISTRATION, TOPICAL; CAFFEINE; CELLULOSE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG CARRIERS; DRUG STABILITY; DRUG STORAGE; HEXOSES; HYDROPHOBICITY; LIPOSOMES; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; POLYSORBATES; SURFACE-ACTIVE AGENTS; TEMPERATURE;

EID: 36248956708     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540701603597     Document Type: Article

References (23)

1. Alssara, I. A., Bosela, A. A., Ahmed, S. M., and Mahrous, G. M. 2004. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 20:1-6.
2. Amato, M., Isenschemid, M., and Huppi, P. 1991. Percutaneous caffeine application in the treatment of neonatal apnoea. Eur. J. Pediatr. 150:592-594.
3. Baker, R. W., and Lonsdale, H. S. 1974. Controlled release: mechanisms and rates. In Controlled Release of Biologically Active Agents, ed. Tanquary, A. C., and Lacey, R. E. 15-71. New York: Plenum Press.
4. Dias, M., Farinha, A., Faustino, E., Hadgraft, J., Pais, J., and Toscano, C. 1999. Topical delivery of caffeine from some commercial formulations. Int. J. Pharm. 182:41-47.
5. Essig, D., Costill, D. L., and Van Handel, P. J. 1980. Effects of caffeine ingestion on muscle glycogen and lipid during leg ergometer cycling. Int. J. Sports Med. 1:86-90.
6. Fadda, A. M., Baroli, B. M., Maccioni, A. M., Sinico, C., Valenti, D., and Alhaique, F. 1998. Phospholipid-detergent systems: effects of polysorbates on the release of liposomal caffeine. Il Farmaco 53:650-654.
7. Israelachvili, J. N. 1985. Intermolecular and Surface Forces, Sydney: Academic Press.
8. Lawrence, M. J., Chauhan, S., Lawrence, S. M., and Barlow, D. J. 1996. The formation, characterization and stability of nonionic surfactant vesicles. STP Pharma. Sci. 6:49-60.
9. Lu, Y. P., Lou, Y. R., Peng, Q. Y., Xie, J. G., and Conney, A. H. 2004. Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in the epidermis of p53 and Bax knockout mice. Cancer Res. 64:5020-5027.
10. Lu, Y. P., Lou, Y. R., Xie, J. G., Peng, Q. Y., Liao, J., Yang, C. S., and Huang, M. T. 2002. Topical applications of caffeine or ()-epicatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. USA 99:12455-12460.
11. Manosroi, A., Wongtrakul, P., Manosroi, J., Saki, H., Sugawara, F., Yuasa, M., and Abe, M. 2003. Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol. Colloid. Surfaces B: Biointerf. 30:129-138.
12. Memisoglu, E., Öner, F., Ayhan, A., Basaran, I., and Hincal, A. A. 1997. In vivo evaluation of rhGM-CSF wound-healing efficacy in topical vehicles. Pharm. Dev. Tech. 2:171-180.
13. Palozza, P., Muzzalupo, R., Trombino, S., Valdannini, A., and Picci, N. 2006. Solubilization and stabilization of β-carotene in niosomes: delivery to cultured cells. Chem. Phys. Lipids 139:32-42.
14. Pardakhty, A., Varshosaz, J., and Rouholamini, A. 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int. J. Pharm. 328:130-141.
15. Sawynok, J., and Yaksh, T. L. 1993. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45:43-85.
16. Schreiber, S., Mahmoud, A., Vuia, A., Rubbelke, M. K., Schmidt, E., Schaller, M., Kandarova, H., et al., 2005. Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol. In Vitro 19:813-822.
17. Shiraki, K., Andoh, T., Imakita, M., Kurokawa, M., Kuraishi, Y., Niimura, M., and Kageyama, S. 1998. Caffeine inhibits paresthesia induced by herpes simplex virus through action on primary sensory neurons in rats. Neurosci. Res. 31:235-240.
18. Tabbakhian, M., Tavakoli, N., Jaafari, M. R., and Daneshamouz, S. 2006. Enhancement of follicular delivery of finasteride by liposomes and niosomes: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int. J. Pharm. 323:1-10.
19. Touitou, E., Levy-Schaffer, F., Dayan, N., Alhaique, F., and Riccieri, F. M. 1994. Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int. J. Pharm. 103:131-136.
20. Varshosaz, J., Tavakoli, N., and Kheirolahi, F. 2006. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS Pharm. Sci. Tech. 7(1) article 24.
21. Waranuch, N., Ramachandran, C., and Weiner, N. D. 1998. Controlled topical delivery of cyclosporin-A from nonionic liposomal formulation: mechanistic aspects. J. Liposome Res. 8:225-238.
22. Yamamura, J., Koyasu, M., Sato, H., Kurokawa, M., Yoshida, Y., Amahabu, Y., and Shiraki, K. 1996. Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon). J. Dermatol. Sci. 12:50-55.
23. Yoshioka, T., Strenberg, B., and Florence, A. T. 1994. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int. J. Pharm. 105:1-6.